Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Clinpro Tooth Creme is a remineralizing dental paste developed by 3M Oral Care, containing 0.21% sodium fluoride (950 ppm fluoride) and a proprietary functionalized tri-calcium phosphate (fTCP). It is indicated for the prevention of dental caries and the remineralization of white spot lesions, particularly following orthodontic treatment. The fTCP technology allows calcium and phosphate ions to coexist with fluoride in the toothpaste without reacting prematurely. Upon application and contact with saliva, the protective barrier on the fTCP breaks down, releasing calcium and phosphate to work synergistically with fluoride to promote the formation of high-quality mineral (fluorapatite) within the tooth structure, thereby strengthening the enamel and increasing its resistance to acid-driven demineralization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Clinpro Tooth Creme.